Table 3.
Hypertensive patients (600) | Normotensive patients (959) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Direct effect | Indirect effect | Total effect | Direct effect | Indirect effect | Total effect | |||||||
Endogenous variables | Coeff | P | Coeff | P | Coeff | P | Coeff | P | Coeff | P | Coeff | P |
Model 1 | ||||||||||||
eGFR | – | – | – | – | – | – | – | – | – | – | – | – |
PWV | 0.124 | <0.001 | – | – | 0.124 | <0.001 | 0.099 | 0.001 | – | – | 0.099 | 0.001 |
SBP | 0.125 | <0.001 | 0.039 | <0.001 | 0.163 | <0.001 | 0.116 | <0.001 | 0.022 | 0.001 | 0.138 | <0.001 |
Model 2 | ||||||||||||
eGFR | – | – | −0.047 | <0.001 | −0.047 | <0.001 | – | – | −0.037 | 0.002 | −0.037 | 0.002 |
PWV | 0.140 | <0.001 | – | – | 0.140 | <0.001 | 0.105 | 0.001 | – | – | 0.105 | 0.001 |
SBP | 0.125 | <0.001 | 0.048 | <0.001 | 0.173 | <0.001 | 0.116 | <0.001 | 0.026 | 0.003 | 0.142 | <0.001 |
Adjusted for uric acid, urinary albumin/creatinine ratio, LDL‐Cholesterol and serum glucose. In the hypertensive patients we also adjusted for the use of antihypertensive treatment.